Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Crinetics Pharmaceuticals Inc 6055 Lusk Boulevard San Diego CA 92121 USA

www.crinetics.com Employees: 437 P: 858-450-6464

Sector:

Medical

Description:

CRINETICS PHARMACEUTICALS is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. CRINETICS PHARMACEUTICALS is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 5,313,003
Enterprise Value, $K 5,048,453
Shares Outstanding, K 94,892
Float, K 90,527
% Float 95.40%
Short Interest, K 13,334
Short Float 14.05%
Days to Cover 14.38
Short Volume Ratio 0.81
% of Insider Shareholders 4.60%
% of Institutional Shareholders 98.51%

Financials:

Annual Sales, $ 1,040 K
Annual Net Income, $ -298,410 K
Last Quarter Sales, $ 140 K
Last Quarter Net Income, $ -130,090 K
EBIT, $ -477,860 K
EBITDA, $ -490,010 K

Growth:

1-Year Return 47.93%
3-Year Return 182.78%
5-Year Return 267.87%
5-Year Revenue Growth -12.61%
5-Year Earnings Growth -76.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.38 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -4.53
EPS Growth vs. Prev Qtr -12.20%
EPS Growth vs. Prev Year -43.75%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CRNX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -35.09%
Return-on-Assets % -32.04%
Profit Margin % -28,693.27%
Debt/Equity 0.00
Price/Sales 3,398.92
Price/Cash Flow N/A
Price/Book 4.96
Book Value/Share 11.30
Interest Coverage -1.99
60-Month Beta 0.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar